Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to give their informed consent to participate in the study.
- People with a Body Mass Index (BMI) above 30 kg/m² (a measure that indicates obesity).
- People who have insulin resistance (shown by a fasting blood insulin level above 62 pmol/L) and/or prediabetes (shown by a fasting blood sugar level between 5.3 and 7.0 mmol/L).
- People whose weight has remained stable for the 3 months before joining the study.
- Women who have gone through menopause (at least 1 year since their last period).
Who may not be able to join:
- People who take any medications, except for those used to treat metabolic syndrome (a group of conditions including high blood pressure, high blood sugar, and excess body fat).
- People who have a medical condition that could affect the study's results or design.
- People who have a history of any psychiatric disorder, including eating disorders.
- People who work shift work (irregular or rotating work hours).
- People who do intensive sport or exercise for more than 3 hours per week.
- People who currently smoke.
- People who misuse drugs or drink more than 3 units of alcohol per day.
- People who have a medical reason why they cannot have an MRI scan.
- People with a known intolerance to lactose or gluten.
- People with a known allergy to soy, eggs, milk, or peanuts.
- People whose obesity began in childhood.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mireille JM Serlie, MD PhD, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phone: +31 683238752
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insulin Sensitivity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.